Benzinga•2026-04-15
Truist Securities Maintains Buy on Vericel, Lowers Price Target to $42VCEL — Vericel Corp
NASDAQ · Biotechnology · Biotechnology
$33.67-7.85%Market cap1.66B
- Latest Close
- $33.67
- 30-Day Move
- -7.9%
- Market Cap
- $1.7B
- Shares Outstanding
- 50,760,000
- P/E Ratio
- 99.62
- P/B Ratio
- 5.14
Analyst consensus: Buy · 14 analysts
NASDAQ:VCELBiotechnology / BiotechnologyDelayed public snapshot
Vericel Corp
A read-only Alphactor snapshot forVericel Corp. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-21
Topline snapshot
Latest Close
$33.67
30-Day Move
-7.9%
Market Cap
$1.7B
Shares Outstanding
50,760,000
P/E Ratio
99.62
P/B Ratio
5.14
Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot
$33.67
-7.9%last 90 delayed daily bars
Market cap$1.7B
90D High
$41.65
90D Low
$28.95
Avg Volume
580,905
What stands out
Gross margin is running at 74.4%, which gives a quick read on operating quality before you open the full model.
Net margin is 6.0%, useful for comparing VCEL against peers in Biotechnology.
VCEL is down 7.9% over the last 30 trading days shown on this page.
Latest operating income is $11M, which helps anchor the headline ratios with an actual earnings figure.
Research snapshot
Composite Fair Value
$20.16
Rule of 40
25.4%
Fundamentals snapshot
Latest Close
$33.67
30-Day Move
-7.9%
Market Cap
$1.7B
Shares Outstanding
50,760,000
P/E Ratio
99.62
P/B Ratio
5.14
ROE
4.7%
ROA
3.4%
Gross Margin
74.4%
Operating Margin
4.0%
Net Margin
6.0%
Debt / Equity
0.01
Current Ratio
5.03
Latest Revenue
$276M
Financial statement snapshot
Revenue
$276M
Gross Profit
$206M
Operating Income
$11M
Net Income
$17M
Gross Margin
7442.0%
Net Margin
598.0%
Current Ratio
5.03
Debt / Equity
0.01
Valuation snapshot
Fair Value
$20.16
Upside / Downside
-40.1%
Signal
Overvalued
Implied Growth
23.9%
DCF
$13.04
EV/Rev
$27.29
Growth Assumption
18.9%
Discount Rate
9.6%
Terminal Growth
2.0%
Base FCF
$25M
Valuation spread
Current Price
$33.67
Composite Fair Value
$20.16
DCF
$13.04
EV/Rev
$27.29
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
High growth priced in
Quality snapshot
Altman Z
7.51
Safe
Piotroski
8
Strong (7-9)
Cash Conversion
3.14x
Rule of 40
25.4%
Acceptable
Annual financial history
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $164M | $-17M | $-17M | $10M |
| 2023-12-31 | $198M | $-6M | $-3M | $8M |
| 2024-12-31 | $237M | $5M | $10M | $-6M |
| 2025-12-31 | $276M | $11M | $17M | $25M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
News snapshot
After signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
Insider activity snapshot
Buy Value
$0
Sell Value
$2M
Buys
0
Sells
6
Buy Value
$0
Sell Value
$2M
Buy/Sell Ratio
0.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
Recent insider transactions
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-02 | Hopper Jonathan Mark | M | 3,472 | $0.00 |
| 2026-04-02 | Hopper Jonathan Mark | Sell | 3,472 | $35.00 |
| 2026-04-02 | Hopper Jonathan Mark | M | 3,472 | $10.95 |
| 2026-03-25 | Rubino Alan L | M | 15,000 | $0.00 |
| 2026-03-25 | Rubino Alan L | M | 15,000 | $2.76 |
| 2026-03-23 | Hagen Heidi | M | 15,000 | $0.00 |
| 2026-03-23 | Hagen Heidi | Sell | 15,000 | $32.41 |
| 2026-03-23 | Hagen Heidi | M | 15,000 | $2.76 |
Institutional holders snapshot
BlackRock
Filed 2024-05-10
$415M
--
Vanguard Group
Filed 2025-05-09
$156M
+0.2%
Invesco
Filed 2025-08-13
$85M
-12.3%
FMR LLC (Fidelity)
Filed 2026-02-17
$78M
+7.7%
Geode Capital Management
Filed 2025-08-08
$53M
+3.2%
Capital Research Global Investors
Filed 2025-08-13
$36M
--
Analyst consensus?
Rating(?)
4.21
Consensus
BuyTarget Mean(?)
—
Target High(?)
—
Target Low(?)
—
Analysts
14
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.
Balance Sheet Deep Dive
Balance sheet changes lead income statements by 2-6 quarters. Net debt, receivables days, and goodwill are the lines that move stocks first.